The structural basis for serotype-specific neutralization of dengue virus by a human antibody
about
Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the hostSpecificity, cross-reactivity and function of antibodies elicited by Zika virus infectionThe Cellular Bases of Antibody Responses during Dengue Virus InfectionStructure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant EpitopeRecent advances in understanding dengueThe Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityDengue structure differs at the temperatures of its human and mosquito hostsImmature and Mature Dengue Serotype 1 Virus Structures Provide Insight into the Maturation ProcessA potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surfaceDengue: an update on treatment optionsMapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and VaccinationProtective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus InfectionComparative Normal Mode Analysis of the Dynamics of DENV and ZIKV CapsidsDengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directionsStructural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal AntibodyDengue: knowledge gaps, unmet needs, and research prioritiesA single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesisThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisA human antibody against Zika virus crosslinks the E protein to prevent infectionHumoral cross-reactivity between Zika and dengue viruses: implications for protection and pathologyCovalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitopeProtection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.Current Status of Dengue Therapeutics Research and Development.Dengue: challenges for policy makers and vaccine developers.Dissecting the human serum antibody response to secondary dengue virus infectionsImmune correlates for dengue vaccine developmentDengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccineMechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.Dengue vaccines: recent developments, ongoing challenges and current candidates.The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope proteinDifferential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates.Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.Antibody responses in humans infected with newly emerging strains of West Nile Virus in EuropeAnalysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases.The type-specific neutralizing antibody response elicited by a dengue vaccine candidate is focused on two amino acids of the envelope protein.
P2860
Q23925011-C9B6D312-E57B-4E58-BC51-2AB0D06A3F5FQ26252507-E3D41A74-3916-496F-B09A-AC6FFDEBD9D1Q26700056-DB912C67-FFBF-443C-B733-7AC7964BE0DBQ26700120-50F67595-55FD-4C64-BF4F-972220002471Q26766156-A4CFE12A-0B3D-485A-BB4A-1A039329D110Q26995782-E7217C9F-5141-4A84-8104-062E5AE0B160Q27654848-6C3517B6-A19F-4D8D-A9E2-FA0E27B27DFEQ27677270-ABFBB588-EA42-4D65-ABF4-D7D5521045DFQ27677965-6B70DBE4-5395-4E64-B2BB-0E54B6C1306BQ27681319-50D1749A-8399-4A90-97E8-88BF664327C1Q28085044-23483699-F5C1-40A0-8DBF-239AC59DDD20Q28114614-A671D426-F092-4BB9-994F-033792C71F4EQ28119679-F80C9B69-6A84-4F2B-810C-52884172FB22Q28353933-692D6AB9-CC2A-497F-B367-B764B0DBB4DBQ28542607-CEAF7EA4-1126-45C8-A0DF-DF4FBD77932FQ28550496-07B2FD10-13A8-475A-884F-A3024B48BCBDQ28729764-A28699A2-0BF2-4263-8C7C-66A5D5BFDDFCQ28804076-2572A32E-C192-4F2A-A5A4-05E633AFCD91Q28804225-EAD984CC-BAEA-4C04-BEFC-760E3AECBA5EQ28950443-197D5C9C-BDD3-44C8-9581-5129BFC7E48EQ29994510-9BA481E0-37B0-49C0-9D65-6112ED7C8053Q30250932-2FCAC953-8765-4320-833B-539889E8E646Q33414156-B524E44F-93FA-48B8-AB5B-80D9221DB184Q33425879-555060B9-50EF-4A20-8BC7-FA4F7EB30324Q33552896-238D4718-FA4E-4D6C-9D20-72B353FEE6E8Q33624327-74E35AF5-FBD9-4477-97EA-5792E5E22691Q33728716-D6B360CB-8419-41C3-A2CC-E6E20C1F79F0Q33924674-F7D48075-20AB-4A27-B5F8-365E0BEC5587Q34042859-E374A4D3-01AD-47FB-B907-A7DAC60D0247Q34262245-144289AF-E989-439C-94E5-299AD12E6C55Q34306877-D59958CA-69B2-4086-BAA8-2B941FE8FCCEQ34367194-7E420888-9E23-4DF3-BC61-C057DF510CAFQ34386384-F33B285A-7457-4F6F-9813-639B9CC57479Q34518791-9F93A912-7E44-46C2-9682-2BCC299346F5Q34522384-FFE34AA4-385D-46BD-B6A5-65792DEEEB03Q34593818-3E1D5184-7FB3-4AE0-9F78-1A0B83A98AE1Q34594111-75B03630-2F8B-4424-8BA6-0AC7467E00B6Q34776746-0C78C042-A9A5-41ED-BBD2-29363BCED6E8Q34999885-8AB7EB81-7953-4D57-A314-BA06A01C11DDQ35069160-B204C6CC-EE37-4538-838E-53CF8E5C84E4
P2860
The structural basis for serotype-specific neutralization of dengue virus by a human antibody
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The structural basis for serot ...... ngue virus by a human antibody
@ast
The structural basis for serot ...... ngue virus by a human antibody
@en
The structural basis for serot ...... ngue virus by a human antibody
@nl
type
label
The structural basis for serot ...... ngue virus by a human antibody
@ast
The structural basis for serot ...... ngue virus by a human antibody
@en
The structural basis for serot ...... ngue virus by a human antibody
@nl
prefLabel
The structural basis for serot ...... ngue virus by a human antibody
@ast
The structural basis for serot ...... ngue virus by a human antibody
@en
The structural basis for serot ...... ngue virus by a human antibody
@nl
P2093
P2860
P50
P3181
P1476
The structural basis for serot ...... ngue virus by a human antibody
@en
P2093
Angeline P C Lim
Annie Hoi Yi Chan
Brendon J Hanson
D Michael Kemeny
Dale Fisher
Ee Ping Teoh
En Wei Teo
Grace K Tan
Jowin K W Ng
P2860
P304
P3181
P356
10.1126/SCITRANSLMED.3003888
P407
P5008
P577
2012-06-20T00:00:00Z